Phase II trials of hexamethylmelamine, dianhydrogalactitol, razoxane, and beta-2'-deoxythioguanosine as single agents against advanced measurable tumors of the pancreas. Gastrointestinal Tumor Study Group.

Cancer Treat Rep ; 69(6): 713-6, 1985 Jun.

Article in En | MEDLINE | ID: mdl-3926311

Subject(s)

Adenocarcinoma/drug therapy; Altretamine/therapeutic use; Antineoplastic Agents/therapeutic use; Deoxyguanosine/analogs & derivatives; Dianhydrogalactitol/therapeutic use; Pancreatic Neoplasms/drug therapy; Piperazines/therapeutic use; Razoxane/therapeutic use; Sugar Alcohols/therapeutic use; Thionucleosides/therapeutic use; Triazines/therapeutic use; Antineoplastic Agents/toxicity; Deoxyguanosine/therapeutic use; Drug Evaluation; Humans; Leukopenia/chemically induced; Thrombocytopenia/chemically induced

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Piperazines / Razoxane / Sugar Alcohols / Thionucleosides / Triazines / Adenocarcinoma / Altretamine / Deoxyguanosine / Dianhydrogalactitol Limits: Humans Language: En Journal: Cancer Treat Rep Year: 1985 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links